Maze Therapeutics Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Maze Therapeutics Inc 's ROA in the third quarter of 2026?
Maze Therapeutics Inc recorded a cumulative net loss of $-151 million during 12 months ending in the third quarter of 2026, resulting in a negative return on assets (ROA) of -32.29%.

However, within the Healthcare sector 424 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 3450, from total ROA ranking in the second quarter of 2026 at 4150.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	21.96 %	76.08 %	29.27 %	22.97 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-151	-134	-75	-83	47
Return On Assets (TTM)	-32.29 %	-29.95 %	-19.25 %	-22.89 %	13.5 %
MAZE's Total Ranking	# 3450	# 4150	#	#	#
Total Assets (TTM) in million	515	534	430	397	422
Seq. Total Assets Change	-3.68 %	24.21 %	8.34 %	-5.91 %	39.05 %
Seq. Net Income Change	-	-	-	-	-

MAZE's 5 Years Annual ROA >> Back to MAZE Management Effectiveness >> Compare MAZE ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 44
Sector	# 425
Overall	# 3627

Return On Assets Statistics
High	Average	Low
-19.38 %	-24.15 %	-30.18 %
(Mar 31 2026)		(Jun 30 2026)

Financial Statements
Maze Therapeutics Inc 's Assets	$ 515 million	MAZE's Balance sheet
Maze Therapeutics Inc 's Income	$ -48 million	Quarterly MAZE's Income Statement
MAZE's Income by Division		See MAZE's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	415	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-131	0	0	0	0
Annual Return On Assets	-31.58 %	-	-	-	-

MAZE's 5 Years Annual ROA >> Back to MAZE Management Effectiveness >> Compare MAZE ROA to its Competitors

More Return On Assets Ratios
MAZE's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MAZE's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MAZE's Competitors
Subscribers only: Roa for Maze Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for MAZE's Customers

You may also want to know
MAZE's Roi	MAZE's Inventory Turnover Ratio	MAZE's Growth Rates	MAZE's Dividend Comparisons
	MAZE's Profitability Ratios	MAZE's Asset Turnover Ratio	MAZE's Dividend Growth
MAZE's Roe	MAZE's Valuation Ratios	MAZE's Financial Strength Ratios	MAZE's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector

ROA

Date modified: 2026-11-11T02:37:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.